Circadian misalignment may impact diabetes risk

Circadian misalignment may impact diabetes risk

(HealthDay)—Circadian misalignment decreases insulin sensitivity and increases inflammation, and is independent of sleep loss in men, according to a study published in the June issue of Diabetes.

Rachel Leproult, Ph.D., from the University of Chicago, and colleagues conducted a parallel group design study involving 26 adults. The authors sought to examine whether the misalignment of that typically occurs in shift work involves intrinsic adverse metabolic effects, independently of . The interventions involved three inpatient days with 10-hour bedtimes, followed by eight inpatient days with to five hours and fixed nocturnal bedtimes (circadian alignment), or with delayed bedtimes on four of the eight days with sleep restriction (circadian misalignment).

The researchers found that daily total sleep time was nearly identical in the aligned and misaligned conditions during the intervention (four hours 48 minutes versus four hours 45 minutes, respectively). Insulin sensitivity decreased significantly in both groups after sleep restriction, with no compensatory increase in insulin secretion; inflammation increased in both groups. The reduction in and increase in inflammation both doubled in male participants exposed to circadian misalignment compared with those who maintained regular nocturnal bedtimes.

"Circadian misalignment that occurs in shift work may increase diabetes risk and inflammation, independently of sleep loss," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Team shows why wound healing is impaired in diabetics

Jan 26, 2015

One of the most troubling complications of diabetes is its effect on wound healing. Roughly 15 percent of diabetics will suffer from a non-healing wound in their lifetime. In some cases, these open ulcers on the skin lead ...

Progress in diabetes drug delivery

Jan 22, 2015

A drug therapy for diabetes treatment is being developed by an international research team led by WA scientists, which combines an existing anti-diabetic drug with bile acids to improve the drug's delivery ...

Roux-en-Y surgery can reverse insulin treatment in T2DM

Jan 21, 2015

(HealthDay)—Roux-en-Y gastric bypass surgery (RYGB) strongly predicts insulin cessation after surgery in insulin-treated type 2 diabetes (I-T2D) patients, independent of weight loss, according to a study ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.